Knight Therapeutics Inc T.GUD

Unimpressive Q3 - Still Waiting

[longrun86]

Tales of glory will most certainly not be written about Knight's Q3 performance.

I am still holding my shares.

I am looking forward to the day when it finally signals that it will be a profitable business and generate returns on shareholder capital as measured in Net Income.

It feels like it is coming soon but I've also been feeling this way since 2022!

LR

[EbbFlow88]

I'm actually a bit surprised by the market's reaction. Book value increased to roughly $7.70/share. It's the 3rd straight quarter of operating profit which is the most important metric as the investment in funds vary a lot to swing Net Income. The revaluation for Synergy is great but we'll see where its trading in 6 months after lock-up and what Knight chooses to do with that

[gudisgood]

I'm with you. Although an uneventful quarter in terms of business development, it was a solid quarter in terms of results, and aligns with the financial guidance given earlier. We knew there would be an increase in operating expenses which, as I understand, are all building for future sales, and they were also included in previous financial guidance. The new launches are only slowly getting

[Stockoman1]

I hear you.  6 year and still awaiting the day. Maybe when the grandchildren gradute from college !